| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |